Related Experiment Video
Updated: May 26, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Substituted heteroaromatic compounds: effect on nicotine self-administration in rats
John R Cashman1, Karl Okolotowicz, Matt Cerny
1Human BioMolecular Research Institute, 5310 Eastgate Mall, San Diego, CA 92121, USA. JCashman@hbri.org
Selective human cytochrome P-450 2A6 (hCYP 2A6) inhibitors reduced nicotine self-administration in rats. These compounds offer potential for nicotine harm reduction through a non-neuronal nicotinic acetylcholine receptor and non-human dopamine transporter mechanism.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Nonselective inhibitors of human cytochrome P-450 2A6 (hCYP 2A6) reduce smoking in humans.
- A comprehensive study on selective hCYP 2A6 inhibitors for reducing nicotine self-administration in rats is lacking.
Purpose of the Study:
- To test selective hCYP 2A6 inhibitors for their efficacy in reducing nicotine self-administration in a rat model.
- To investigate the mechanism of action, specifically ruling out involvement of neuronal nicotinic acetylcholine receptors (nAChRs) and the human dopamine transporter (hDAT).
Main Methods:
- Rats were trained to self-administer nicotine intravenously.
- Dose-dependent effects of substituted heteroaromatic compounds on nicotine self-administration were evaluated.
- Operant conditioning assessed nicotine versus food-reinforced responding for key compounds.
Main Results:
- Compounds 10 and 11 selectively decreased nicotine self-administration in rats.
- Estimated ED(50) values were 4 mg/kg for compound 10 and 2.8 mg/kg for compound 11.
- No significant affinity for α4β2- or α7-neuronal nicotinic acetylcholine receptors or inhibition of the human dopamine transporter was observed.
Conclusions:
- Selective hCYP 2A6 inhibitors can reduce nicotine self-administration.
- The mechanism of action does not involve nAChRs or hDAT.
- Chemical analogs of nicotine show promise for nicotine harm reduction.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Nucleophilic Aromatic Substitution: Addition–Elimination (SNAr)
The reaction begins with an attack of the nucleophile on the carbon that holds the leaving group. This results in the delocalization of the π electrons over the ring carbons. The resonance interaction between the...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...

